<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36708816</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6825</ISSN><JournalIssue CitedMedium="Internet"><Volume>151</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium.</ArticleTitle><Pagination><StartPage>1577</StartPage><EndPage>1584.e4</EndPage><MedlinePgn>1577-1584.e4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2023.01.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0091-6749(23)00089-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Rhinoviruses (RVs) are the most common trigger for asthma exacerbations, and there are currently no targeted therapies for viral-induced asthma exacerbations. RV infection causes neutrophilic inflammation, which is often resistant to effects of glucocorticoids. IL-1 receptor antagonist (IL-1RA) treatment reduces neutrophilic inflammation in humans challenged with inhaled endotoxin and thus may have therapeutic potential for RV-induced asthma exacerbations.</AbstractText><AbstractText Label="OBJECTIVE">We sought to test the hypothesis that IL-1RA treatment of airway epithelium reduces RV-mediated proinflammatory cytokine production, which is important for neutrophil recruitment.</AbstractText><AbstractText Label="METHODS">Human bronchial epithelial cells from deceased donors without prior pulmonary disease were cultured at air-liquid interface and treated with IL-13 to approximate an asthmatic inflammatory milieu. Human bronchial epithelial cells were infected with human RV-16 with or without IL-1RA treatment.</AbstractText><AbstractText Label="RESULTS">RV infection promoted the release of IL-1&#x3b1; and the neutrophil-attractant cytokines IL-6, IL-8, and CXCL10. Proinflammatory cytokine secretion was significantly reduced by IL-1RA treatment without significant change in IFN-&#x3b2; release or RV titer. In addition, IL-1RA reduced MUC5B expression after RV infection without impacting MUC5AC.</AbstractText><AbstractText Label="CONCLUSIONS">These data suggest that IL-1RA treatment significantly reduced proinflammatory cytokines while preserving the antiviral response. These results provide evidence for further investigation of IL-1RA as a novel targeted therapy against neutrophil-attractant cytokine release in RV-induced airway inflammatory responses.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schworer</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chason</LastName><ForeName>Kelly D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burbank</LastName><ForeName>Allison J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kesic</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Michelle L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC. Electronic address: michelle_hernandez@med.unc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES010126</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007062</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL135235</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL007106</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR002490</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053590">Interleukin 1 Receptor Antagonist Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017472">Receptors, Interleukin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053590" MajorTopicYN="N">Interleukin 1 Receptor Antagonist Protein</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017472" MajorTopicYN="N">Receptors, Interleukin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004848" MajorTopicYN="N">Epithelium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">IL-13</Keyword><Keyword MajorTopicYN="N">IL-1RA</Keyword><Keyword MajorTopicYN="N">anakinra</Keyword><Keyword MajorTopicYN="N">epithelial cells</Keyword><Keyword MajorTopicYN="N">exacerbations</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement><u>Conflicts of Interest</u>: The authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36708816</ArticleId><ArticleId IdType="mid">NIHMS1870118</ArticleId><ArticleId IdType="pmc">PMC10257744</ArticleId><ArticleId IdType="doi">10.1016/j.jaci.2023.01.015</ArticleId><ArticleId IdType="pii">S0091-6749(23)00089-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Castillo JR, Peters SP, Busse WW. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment. J Allergy Clin Immunol Pract 2017;5:918&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5950727</ArticleId><ArticleId IdType="pubmed">28689842</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinke JW, Borish L. Immune Responses in Rhinovirus-Induced Asthma Exacerbations. Curr Allergy Asthma Rep 2016;16:78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797654</ArticleId><ArticleId IdType="pubmed">27796793</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kluijver J Interleukin-1b and interleukin-1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non-asthmatic subjects. Clin Exp Allergy 2003;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">14519149</ArticleId></ArticleIdList></Reference><Reference><Citation>Denlinger LC, Heymann P, Lutter R, Gern JE. Exacerbation-Prone Asthma. J Allergy Clin Immunol Pract 2020;8:474&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942520</ArticleId><ArticleId IdType="pubmed">31765853</ArticleId></ArticleIdList></Reference><Reference><Citation>Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ, Calatroni A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol 2015;136:1476&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679705</ArticleId><ArticleId IdType="pubmed">26518090</ArticleId></ArticleIdList></Reference><Reference><Citation>Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 2015;70:910&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">25858686</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer S, Sicorschi Gutu C, Grund JC, Chiriac MT, Zirlik S, Finotto S. Regulation and Function of Interferon-Lambda (IFN&#x3bb;) and Its Receptor in Asthma. Front Immunol 2021;12:731807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660125</ArticleId><ArticleId IdType="pubmed">34899691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonser L, Erle D. Airway Mucus and Asthma: The Role of MUC5AC and MUC5B. J Clin Med 2017;6:112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742801</ArticleId><ArticleId IdType="pubmed">29186064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonser LR, Zlock L, Finkbeiner W, Erle DJ. Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J Clin Invest 2016;126:2367&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4887179</ArticleId><ArticleId IdType="pubmed">27183390</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint M, Jackson DJ, Swieboda D, Gued&#xe1;n A, Tsourouktsoglou TD, Ching YM, et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nat Med 2017;23:681&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5821220</ArticleId><ArticleId IdType="pubmed">28459437</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse WW. A role for neutrophils in asthma exacerbations. Nat Med 2017;23:658&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28586342</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson L, Proud D, Hendley J, Hayden F, Gwaltneyjr J. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">8655877</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhou YT, Wang LQ, Li LY, Bao Q, Tian S, et al. NOD-like receptor family, pyrin domain containing 3 (NLRP3) contributes to inflammation, pyroptosis, and mucin production in human airway epithelium on rhinovirus infection. J Allergy Clin Immunol 2019;144:777&#x2013;787.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31102698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Ninaber DK, van Schadewijk A, Hiemstra PS. Tiotropium and Fluticasone Inhibit Rhinovirus-Induced Mucin Production via Multiple Mechanisms in Differentiated Airway Epithelial Cells. Front Cell Infect Microbiol 2020;10:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318795</ArticleId><ArticleId IdType="pubmed">32637364</ArticleId></ArticleIdList></Reference><Reference><Citation>Piper SC, Ferguson J, Kay L, Parker LC, Sabroe I, Sleeman MA, et al. The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells. Tripp R, editor. PLoS ONE 2013;8:e63365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665753</ArticleId><ArticleId IdType="pubmed">23723976</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei ET, Noordhoek JA, Hackett TL, Spanjer AIR, Postma DS, Timens W, et al. Interleukin-1&#x3b1; drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD. Eur Respir J 2016;48:359&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">27418555</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AR, Donaldson JE, Blume C, Smithers N, Tezera L, Tariq K, et al. IL-1&#x3b1; mediates cellular cross-talk in the airway epithelial mesenchymal trophic unit. Tissue Barriers 2016;4:e1206378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993579</ArticleId><ArticleId IdType="pubmed">27583193</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. Immunity 2019;50:778&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174020</ArticleId><ArticleId IdType="pubmed">30995499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez ML, Mills K, Almond M, Todoric K, Aleman MM, Zhang H, et al. IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. J Allergy Clin Immunol 2015;135:379&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4323893</ArticleId><ArticleId IdType="pubmed">25195169</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison CB, Edwards CE, Shaffer KM, Araba KC, Wykoff JA, Williams DR, et al. SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13. Proc Natl Acad Sci 2022;119:e2119680119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9169748</ArticleId><ArticleId IdType="pubmed">35353667</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson ND, Everman JL, Chioccioli M, Feriani L, Goldfarbmuren KC, Sajuthi SP, et al. Single-Cell and Population Transcriptomics Reveal Pan-epithelial Remodeling in Type 2-High Asthma. Cell Rep 2020;32:107872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8046336</ArticleId><ArticleId IdType="pubmed">32640237</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt RJ, Lloyd CM. Regulation of immune responses by the airway epithelial cell landscape. Nat Rev Immunol 2021;21:347&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804588</ArticleId><ArticleId IdType="pubmed">33442032</ArticleId></ArticleIdList></Reference><Reference><Citation>Randell SH, Fulcher ML, editors. Epithelial Cell Culture Protocols [Internet]. Totowa, NJ: Humana Press; 2013. [cited 2022 Apr 6]. (Methods in Molecular Biology; vol. 945). Available from: 10.1007/978-1-62703-125-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-125-7</ArticleId><ArticleId IdType="pubmed">23097104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracie K, Pang S, Jones GM, Faulds K, Braybrook J, Graham D. Detection of cortisol in serum using quantitative resonance Raman spectroscopy. Anal Methods 2017;9:1589&#x2013;94.</Citation></Reference><Reference><Citation>Bhake RC, Kluckner V, Stassen H, Russell GM, Leendertz J, Stevens K, et al. Continuous Free Cortisol Profiles&#x2014;Circadian Rhythms in Healthy Men. J Clin Endocrinol Metab 2019;104:5935&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">31355884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Ribeiro CMP, Sun L, Okuda K, Kato T, Gilmore RC, et al. XBP1S Regulates MUC5B in a Promoter Variant&#x2013;Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia. Am J Respir Crit Care Med 2019;200:220&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6635783</ArticleId><ArticleId IdType="pubmed">30973754</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WM, Chen Y, Wang W, Mosser A. Infectivity Assays of Human Rhinovirus-A and -B Serotypes. In: Jans DA, Ghildyal R, editors. Rhinoviruses [Internet]. New York, NY: Springer New York; 2015. [cited 2022 Apr 18]. p. 71&#x2013;81. (Methods in Molecular Biology; vol. 1221). Available from: 10.1007/978-1-4939-1571-2_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-1571-2_7</ArticleId><ArticleId IdType="pubmed">25261308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lock M, Korn M, Wilson J, Sena-Esteves M, Gao G. Measuring the Infectious Titer of Recombinant Adenovirus Using Tissue Culture Infection Dose 50% (TCID 50 ) End-Point Dilution and Quantitative Polymerase Chain Reaction (qPCR). Cold Spring Harb Protoc 2019;2019:pdb.prot095562.</Citation><ArticleIdList><ArticleId IdType="pubmed">31371467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Sun L, Kato T, Okuda K, Martino MB, Abzhanova A, et al. IL-1&#x3b2; dominates the promucin secretory cytokine profile in cystic fibrosis. J Clin Invest 2019;129:4433&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763234</ArticleId><ArticleId IdType="pubmed">31524632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, Widdicombe JH. Interleukin-13&#x2013;Induced Mucous Metaplasia Increases Susceptibility of Human Airway Epithelium to Rhinovirus Infection. Am J Respir Cell Mol Biol 2010;43:652&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993086</ArticleId><ArticleId IdType="pubmed">20081054</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira Braga FA, Kar G, Berg M, Carpaij OA, Polanski K, Simon LM, et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med 2019;25:1153&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">31209336</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagam A, Footitt J, Marczynski M, Radicioni G, Cross MT, Finney LJ, et al.
Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.
J Clin Invest [Internet]
2022.  [cited
2022 Mar 13]; Available from: http://www.jci.org/articles/view/120901</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012283</ArticleId><ArticleId IdType="pubmed">35239513</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Tang XX. Abnormal Airway Mucus Secretion Induced by Virus Infection. Front Immunol 2021;12:701443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505958</ArticleId><ArticleId IdType="pubmed">34650550</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei ET, Brandsma CA, Timens W, Heijink IH, Hackett TL. Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD. Eur Respir J 2020;55:1900563.</Citation><ArticleIdList><ArticleId IdType="pubmed">31727692</ArticleId></ArticleIdList></Reference><Reference><Citation>Terajima M, Yamaya M, Sekizawa K, Okinaga S, Suzuki T, Yamada N, et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1&#x3b2;. Am J Physiol-Lung Cell Mol Physiol 1997;273:L749&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">9357849</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei ET B Mosta&#xe7;o-Guidolin L, Hsieh A, Warner SM, AL-Fouadi M, Wang M, et al. Epithelial-interleukin-1 inhibits collagen formation by airway fibroblasts: Implications for asthma. Sci Rep 2020;10:8721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250866</ArticleId><ArticleId IdType="pubmed">32457454</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillette DD, Shah PA, Cremer T, Gavrilin MA, Besecker BY, Sarkar A, et al. Analysis of Human Bronchial Epithelial Cell Proinflammatory Response to Burkholderia cenocepacia Infection. J Biol Chem 2013;288:3691&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3567624</ArticleId><ArticleId IdType="pubmed">23269671</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakebread JA, Haitchi HM, Xu Y, Holgate ST, Roberts G, Davies DE. Rhinovirus-16 Induced Release of IP-10 and IL-8 Is Augmented by Th2 Cytokines in a Pediatric Bronchial Epithelial Cell Model. Cormier SA, editor. PLoS ONE 2014;9:e94010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3976391</ArticleId><ArticleId IdType="pubmed">24705919</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts N, Al Mubarak R, Francisco D, Kraft M, Chu HW. Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL&#x2010;13 treatment. Clin Transl Med [Internet] 2018. [cited 2020 Jul 25];7. Available from: 10.1186/s40169-018-0189-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40169-018-0189-2</ArticleId><ArticleId IdType="pmc">PMC5931947</ArticleId><ArticleId IdType="pubmed">29721720</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman MC, Gill MA, Whalen E, Babineau DC, Shao B, Liu AH, et al. Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children. Nat Immunol 2019;20:637&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472965</ArticleId><ArticleId IdType="pubmed">30962590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakiela B, Gielicz A, Plutecka H, Hubalewska-Mazgaj M, Mastalerz L, Bochenek G, et al. Th2-type cytokine induced mucous metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection. Am J Respir Cell Mol Biol 2014;140303121456001.</Citation><ArticleIdList><ArticleId IdType="pubmed">24588727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachowicz-Scroggins ME, Yuan S, Kerr SC, Dunican EM, Yu M, Carrington SD, et al. Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. Am J Respir Crit Care Med 2016;194:1296&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5114443</ArticleId><ArticleId IdType="pubmed">27845589</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, et al. Muc5b is required for airway defence. Nature 2014;505:412&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001806</ArticleId><ArticleId IdType="pubmed">24317696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis CW, et al. Airway Mucin Concentration as a Marker of Chronic Bronchitis. N Engl J Med 2017;377:911&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5706541</ArticleId><ArticleId IdType="pubmed">28877023</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper Type 2&#x2013;driven Inflammation Defines Major Subphenotypes of Asthma. Am J Respir Crit Care Med 2009;180:388&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742757</ArticleId><ArticleId IdType="pubmed">19483109</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmutovic Persson I, Menzel M, Ramu S, Cerps S, Akbarshahi H, Uller L. IL-1&#x3b2; mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation. Respir Res 2018;19:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5781288</ArticleId><ArticleId IdType="pubmed">29361942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22561835</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>